EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting the Metastatic Potential of Papillary Thyroid Microcarcinoma Based on the Molecular Profile of Preoperative Cytology Specimens

Sergei A Lukyanov iD, Sergei E Titov iD, Aria V Dzodzaeva, Vladimir E Vanushko, Dmitry G Beltsevich, Yuliya A Veryaskina iD, Semyon V Kupriyanov, Ekaterina V Bondarenko iD, Ekaterina A Troshina, Liliya S Urusova iD, Sergei V Sergiyko

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sergei A Lukyanov und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, South Ural State Medical University, 454141 Chelyabinsk, Russia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary, Biomarkers, Tumor. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The study was supported by the Russian Science Foundation, This research was funded by the Ministry of Science and Higher Education of the Russian Federation, The study was supported by the Tomsk State University Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The strategy of active surveillance for papillary thyroid microcarcinoma (PTMC) is becoming increasingly popular within the global medical community. A key criterion for selecting this strategy is the absence of any signs of lymphogenic or distant metastases. The present study assessed the diagnostic accuracy of molecular genetic markers for predicting the metastatic potential of patients with PTMC. We evaluated the expression levels of 33 molecular genetic markers in cytology samples from 92 patients with PTMC and confirmed histological diagnosis. Among these patients, 32 had metastases to regional cervical lymph nodes. Our findings revealed the upregulated expression of the HMGA2, TIMP1, and FN1 genes, as well as microRNA-146b, in patients with metastatic PTMC. Conversely, we found the downregulated expression of miRNA-7 and -148b in metastatic tumors. In metastatic tumors, significant reductions were observed in DIO1 activity (11-fold), TFF3 gene expression (8-fold), TPO expression (4-fold), and SLC26A7 expression (2.6-fold). All the markers exhibited high sensitivity (84.5–90.6%) in detecting metastatic PTMC, although the specificity proved to be low. The use of molecular markers to predict lymphogenic metastatic spread in patients with PTMC could enhance existing risk grading systems. Such assessments can already be applicable at the preoperative stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryBiomarkers, TumorHumansMiddle AgedFemaleMaleAdultLymphatic MetastasisMicroRNAsGene Expression Regulation, NeoplasticAgedNeoplasm Metastasis

Stichwörter der Autor:innen

FN1HMGA2SLC26A7TIMP1metastaticmiRNA-146bmiRNA-148bmiRNA-7molecular testingpapillary thyroid microcarcinoma

Substanzen

Biomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Department of General Surgery, South Ural State Medical University, 454141 Chelyabinsk, Russia.
  • Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
  • AO Vector-Best, 630117 Novosibirsk, Russia.
  • National Medical Research Center for Endocrinology, 115478 Moscow, Russia.
  • Laboratory of Gene Engineering, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
  • Laboratory of Evolutionary Cytogenetics, National Research Tomsk State University, 634050 Tomsk, Russia.

ORCID-Profile: Sergei A Lukyanov, Sergei E Titov, Yuliya A Veryaskina, Ekaterina V Bondarenko, Liliya S Urusova

Förderung

  • The study was supported by the Russian Science Foundation
  • This research was funded by the Ministry of Science and Higher Education of the Russian Federation
  • The study was supported by the Tomsk State University Development Program
  • Russian Science Foundation
  • Ministry of Science and Higher Education of the Russian Federation
  • Tomsk State University Development Program

Zitieren

APA

Lukyanov, S. A., Titov, S. E., Dzodzaeva, A. V., Vanushko, V. E., Beltsevich, D. G., Veryaskina, Y. A., Kupriyanov, S. V., Bondarenko, E. V., Troshina, E. A., Urusova, L. S., & Sergiyko, S. V. (2025). Predicting the Metastatic Potential of Papillary Thyroid Microcarcinoma Based on the Molecular Profile of Preoperative Cytology Specimens. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136418

Vancouver

Lukyanov SA, Titov SE, Dzodzaeva AV, Vanushko VE, Beltsevich DG, Veryaskina YA, et al. Predicting the Metastatic Potential of Papillary Thyroid Microcarcinoma Based on the Molecular Profile of Preoperative Cytology Specimens. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136418

BibTeX
@article{Lukyanov2025,
  author = {Lukyanov, Sergei A and Titov, Sergei E and Dzodzaeva, Aria V and Vanushko, Vladimir E and Beltsevich, Dmitry G and Veryaskina, Yuliya A and Kupriyanov, Semyon V and Bondarenko, Ekaterina V and Troshina, Ekaterina A and Urusova, Liliya S and Sergiyko, Sergei V},
  title = {Predicting the Metastatic Potential of Papillary Thyroid Microcarcinoma Based on the Molecular Profile of Preoperative Cytology Specimens},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136418}
}
Kostenlos starten →